Joint Research And Development Agreement Sample Contracts

JOINT RESEARCH AND DEVELOPMENT AGREEMENT Between THE JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY AND SECOND SIGHT MEDICAL PRODUCTS, INC. (November 6th, 2014)

This Joint Research and Development Agreement ("Agreement") is made and entered into by and between The Johns Hopkins University Applied Physics Laboratory LLC ("JHU/APL"), and Second Sight Medical Products, Inc. ("Company") hereinafter collectively referred to as the Parties.

JOINT RESEARCH AND DEVELOPMENT AGREEMENT Between THE JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY AND SECOND SIGHT MEDICAL PRODUCTS, INC. (October 2nd, 2014)

This Joint Research and Development Agreement ("Agreement") is made and entered into by and between The Johns Hopkins University Applied Physics Laboratory LLC ("JHU/APL"), and Second Sight Medical Products, Inc. ("Company") hereinafter collectively referred to as the Parties.

Emmaus Life Sciences, Inc. – ADDENDUM TO JOINT RESEARCH AND DEVELOPMENT AGREEMENT (The Agreement) by and Between CELLSEED INC. (CELLSEED) and EMMAUS MEDICAL INC. (EMMAUS) (May 8th, 2014)

NOW, THEREFORE, in consideration of the mutual promises and undertakings set forth herein, and intending to be legally bound hereby, CELLSEED and EMMAUS do hereby agree and acknowledge as follows:

Joint Research and Development Agreement (November 14th, 2011)

LABORATOIRES MAYOLY SPINDLER SAS, a corporation created and organized under French laws, having its registered office at 6, avenue de l'Europe, 78400 Chatou, France, represented by its President, SCORPIUS SAS, a corporation created and organized under French laws, having its registered office at 55 rue Jouffroy d'Abbans, 75017 Paris, France, itself being represented by its President Mr. Jean-Nicolas VERNIN;

Emmaus Life Sciences, Inc. – ADDENDUM TO JOINT RESEARCH AND DEVELOPMENT AGREEMENT (The "Agreement") by and Between CELLSEED INC. ("CELLSEED") and EMMAUS MEDICAL INC. ("EMMAUS") (October 6th, 2011)

NOW, THEREFORE, in consideration of the mutual promises and undertakings set forth herein, and intending to be legally bound hereby, CELLSEED and EMMAUS do hereby agree and acknowledge as follows:

Joint Research and Development Agreement (September 9th, 2011)

LABORATOIRES MAYOLY SPINDLER SAS, a corporation created and organized under French laws, having its registered office at 6, avenue de l'Europe, 78400 Chatou, France, represented by its President, SCORPIUS SAS, a corporation created and organized under French laws, having its registered office at 55 rue Jouffroy d'Abbans, 75017 Paris, France, itself being represented by its President Mr. Jean-Nicolas VERNIN;

Emmaus Life Sciences, Inc. – Joint Research and Development Agreement (May 4th, 2011)

WHEREAS, EMMAUS has conducted research in the areas of regenerative medicine to develop certain products. From this regenerative medicine research initiative, EMMAUS is interested in assessing the products which have been or will be developed by CELLSEED, either alone or jointly with EMMAUS;

Shengdatech Inc – Contract (April 6th, 2006)

Exhibit 10.17 JOINT RESEARCH AND DEVELOPMENT AGREEMENT Party A: Shandong Shengda Technology Co., Ltd Party B: Qingdao University of Science and Technology In line with the principle of reciprocity and mutual benefit and the operational mechanism of combining "academic research with production", the two parties, after negotiations, agree to jointly establish the Nanotechnology R&D Center, and enter into this Contract as follows: I. The Name of the Research Center: Qingdao University of Science and Technology Shengda Technology Nanotechnology R&D Center (hereinafter referred to as "Research Center") II. The Location of the Research Center: The R&D Center shall be located in Party B's Key Lab of Rubber and Plastic Materials and Engineering under the Ministry of Education. Party B shall be responsible for providing the workplace for this R&D Center and Party A shall be responsible for the deco